HC Wainwright & Co. Reiterates Neutral on Evommune

Benzinga Newsdesk www.benzinga.com Neutral 92.2%

Neg 0% Neu 92.2% Pos 0%

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Evommune (NYSE:EVMN) with a Neutral.

Comments

No comments yet. Be the first!